$79.31
-1.81-2.23%
At close: Sep 11, 5:00 PM EST
$79.31
N/A
After Hours: Sep 11, 4:00 PM EST
Tarsus Pharmaceuticals Inc
TARSNASDAQ
Tarsus Pharmaceuticals Earnings & Forecasts
Tarsus Pharmaceuticals (TARS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Tarsus Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.25 | $-0.39 | $-0.07 | $-0.34 |
| Actual | $-0.43 | $-0.16 | $-0.20 | $-0.30 |
| Surprise | -72.0% | +59.0% | -185.7% | +11.8% |
| Revenue | ||||
| Estimate | $167.2M | $149.8M | $144.7M | $115.3M |
| Actual | $173.9M | $162.1M | $151.7M | $118.7M |
| Surprise | +4.00% | +8.18% | +4.80% | +2.93% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.52 | $-0.08 | $-0.69 | $-0.37 |
| Revenue | ||||
| Consensus | $181.8M | $196.5M | — | — |
